Compare US HB 1927 (2021) and US HB 8013 (2020)

The introduced text of these two bills, side by side, with the wording they share.

922 shared 8-word phrases found in the introduced text of these two bills.

This highlights wording the two bills share in their introduced text. A shared passage may include text that both bills quote from the same existing law, not only language either one drafted. A match shows that the texts overlap; it does not show who drafted a bill, and filing order alone does not show which bill copied which.

US HB 1927 (2021)US HB 8013 (2020)
SESSION H. R. 1927 To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. IN THE HOUSE OF REPRESENTATIVESSESSION H. R. 8013 To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. IN THE HOUSE OF REPRESENTATIVES
introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to theintroduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the
and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 3 (a) SHORT TITLE.—This Act may be cited as the 4 ‘‘End Taxpayer Funding of Gender Experimentation Act 5 ofand Ways and Means, for a period to be subse- quently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To prohibit taxpayer-funded gender reassignment medical interventions, and for other purposes. Be it enacted by the Senate and House of Representa- 1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE; TABLE OF CONTENTS. 3 (a) SHORT TITLE.—This Act may be cited as the 4 ‘‘End Taxpayer Funding of Gender Experimentation Act 5 of
Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1927.IH H1927 pamtmann on DSKBC07HB2PROD with BILLS 2 •HR 1927 IHJkt 099200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H8013.IH H8013 pamtmann on DSKBC07HB2PROD with BILLS 2 •HR 8013 IH
Sec. 1. Short title; table of contents. TITLE I—PROHIBITING FEDERALLY FUNDED GENDER REASSIGNMENT MEDICAL INTERVENTIONS Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interven- tions. Sec. 102. Amendment to table of chapters. TITLE II—APPLICATION UNDER THE AFFORDABLE CARE ACT Sec. 201. Clarifying application of prohibition to premium credits and cost- sharing reductions under ACA. TITLE I—PROHIBITING FEDER- 3 ALLY FUNDED GENDER REAS- 4 SIGNMENT MEDICAL INTER- 5 VENTIONS 6 SEC. 101. PROHIBITING TAXPAYER-FUNDED GENDER REAS- 7 SIGNMENT MEDICAL INTERVENTIONS. 8 Title 1, United States Code, is amended by adding 9 at the end the following new chapter: 10 ‘‘CHAPTER 4—PROHIBITING…Sec. 1. Short title; table of contents. TITLE I—PROHIBITING FEDERALLY FUNDED GENDER REASSIGNMENT MEDICAL INTERVENTIONS Sec. 101. Prohibiting taxpayer-funded gender reassignment medical interven- tions. Sec. 102. Amendment to table of chapters. TITLE II—APPLICATION UNDER THE AFFORDABLE CARE ACT Sec. 201. Clarifying application of prohibition to premium credits and cost- sharing reductions under ACA. TITLE I—PROHIBITING FEDER- 1 ALLY FUNDED GENDER REAS- 2 SIGNMENT MEDICAL INTER- 3 VENTIONS 4 SEC. 101. PROHIBITING TAXPAYER-FUNDED GENDER REAS- 5 SIGNMENT MEDICAL INTERVENTIONS. 6 Title 1, United States Code, is amended by adding 7 at the end the following new chapter: 8 ‘‘CHAPTER 4—PROHIBITING T…
testing that the individual does not have normal sextesting that the individual does not have normal sex
Jkt 019200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1927.IH H1927 pamtmann on DSKBC07HB2PROD with BILLS 6 •HR 1927 IHJkt 099200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H8013.IH H8013 pamtmann on DSKBC07HB2PROD with BILLS 7 •HR 8013 IH
C) estrogen to biological males at doses 24 that are supraphysiologic to the male sexC) estrogen to biological males at doses 1 that are supraphysiologic to the male sex
Jkt 019200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H1927.IH H1927 pamtmann on DSKBC07HB2PROD with BILLS 7 •HR 1927 IHJkt 099200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H8013.IH H8013 pamtmann on DSKBC07HB2PROD with BILLS 8 •HR 8013 IH
Code, 2 is amended by adding at the end the following newCode is amended by 5 adding at the end the following new
of the Internal Revenue Code 16 of 1986 is amendedof the Internal Revenue Code of 16 1986 is amended
any health 18 plan that includes coverage for gender reassign- 19 ment medical interventions (other than any 20 gender reassignment medical intervention or 21 treatment described in section 306 or 307 of 22 title 1, United States Codeany health plan 2 that includes coverage for gender reassignment 3 medical interventions (other than any gender 4 reassignment medical intervention or treatment 5 described in section 306 or 307 of title 1, 6 United States Code
Jkt 019200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H1927.IH H1927 pamtmann on DSKBC07HB2PROD with BILLS 8 •HR 1927 IHJkt 099200 PO 00000 Frm 00010 Fmt 6652 Sfmt 6201 E:\BILLS\H8013.IH H8013 pamtmann on DSKBC07HB2PROD with BILLS 11 •HR 8013 IH
is amended by 3 adding at the end the following newis 11 amended by adding at the end the following new
Jkt 019200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H1927.IH H1927 pamtmann on DSKBC07HB2PROD with BILLS 9 •HR 1927 IHJkt 099200 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 E:\BILLS\H8013.IH H8013 pamtmann on DSKBC07HB2PROD with BILLS 12 •HR 8013 IH

Only the first shared passages are listed here; the side-by-side view shows them all.